SCHEMBL7526652

SCHEMBL7526652

O=C(O)CCC(=O)c1ccc2c(c1)CNC(=O)N2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 2/20 0.47
PDE3A Q14432 2/20 0.47
PKM P14618 1/20 0.43
TSHR P16473 1/20 0.43
CYP11B1 P15538 2/20 0.42
CYP11B2 P19099 2/20 0.42
ALDH1A1 P00352 2/20 0.42
KMT2A Q03164 1/20 0.41
EPHX2 P34913 1/20 0.40
NR4A2 P43354 1/20 0.40
CYP1A2 P05177 3/20 0.40
HPGD P15428 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B10 Q99714 1/20 0.40
FFAR1 O14842 1/20 0.40
LMNA P02545 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HIF1A Q16665 1/20 0.40
CRBN Q96SW2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8545280 0.86 PDE3B (0.47) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL7418793 0.83 PDE3B (0.49) PDE3BPDE3ACYP11B1CYP11B2EPHX2
SCHEMBL18114133 0.83 PDE3B (0.49) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL4859709 0.83 PDE3B (0.44) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL31032797 0.82 PDE3B (0.54) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL5366326 0.82 PDE3B (0.54) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL9196020 0.77 ALDH1A1 (0.54) PDE3BPDE3ACYP11B1CYP11B2ALDH1A1
SCHEMBL7413152 0.77 BRD4 (0.54) PKMTSHRKMT2AHTR1ADRD2
SCHEMBL6035329 0.76 TDP1 (0.39) ALDH1A1LMNARAB9ASMN1; SMN2HTR1A
SCHEMBL23217085 0.75 KDM4E (0.55) PKMTSHRALDH1A1CYP2C19DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4906630-A Method of increasing cardiac contractility using pharmaceutical compositions comprising benzodiazinone- pyridazinone or hydroxy-pyrazolyl compounds RORER PHARMACEUTICAL CORPORATION (US) 1990-03-06 US disclosed
US-4868300-A INOTROPIC AGENTS, CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1989-09-19 US disclosed
US-4785101-A CONGESTIVE HEART FAILURE RORER PHARMACEUTICAL CORPORATION (US) 1988-11-15 US disclosed
EP-0247177-A4 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES. RORER INTERNAT OVERSEAS INC (US) 1988-04-06 EP disclosed
US-4725686-A CONGESTIVE HEART FAILURE WILLIAM H. RORER, INC. (US) 1988-02-16 US disclosed
EP-0247177-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (a Delaware corporation) (US) 1987-12-02 EP disclosed
WO-1987003201-A1 BENZODIAZINONE-PYRIDAZINONE AND HYDROXY-PYRAZOLYL COMPOUNDS, CARDIOTONIC COMPOSITIONS INCLUDING THE SAME, AND THEIR USES RORER INTERNATIONAL (OVERSEAS) INC. (US) 1987-06-04 WO disclosed